Literature DB >> 8208546

Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells.

A Fernandez1, M C Marin, T McDonnell, H N Ananthaswamy.   

Abstract

In this study, we investigated the role of activated Ha-ras oncogene on the growth-regulatory properties of tumor necrosis factor (TNF) in C3H mouse embryo fibroblasts. TNF-resistant 10T1/2 cells transfected with an activated Ha-ras oncogene not only produced tumors in nude mice but also exhibited extreme sensitivity to cytolysis by TNF. TNF-induced cell death was mediated through apoptosis. The differential sensitivity of normal and Ha-ras transformed cells to TNF was not due to differences in the number of TNF receptors on their cell surface. However, TNF-resistant cells, but not sensitive cells, overexpressed bcl-2, c-myc, and manganese superoxide dismutase (MnSOD) mRNA following exposure to TNF. In addition, TNF treatment resulted in a marginal induction of p53 mRNA in both TNF-sensitive and resistant cells. These results suggest that TNF-induced cytotoxicity involves apoptosis and that TNF-induced over-expression of bcl-2, c-myc, and MnSOD genes is associated with TNF resistance in C3H mouse embryo fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208546

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death.

Authors:  P Mehlen; C Kretz-Remy; X Préville; A P Arrigo
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism.

Authors:  M Mills; K C Meysick; A D O'Brien
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Ras signaling in tumor necrosis factor-induced apoptosis.

Authors:  J C Trent; D J McConkey; S M Loughlin; M T Harbison; A Fernandez; H N Ananthaswamy
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

Review 4.  Importance of the Bcl-2 family in cell death regulation.

Authors:  T J McDonnell; A Beham; M Sarkiss; M M Andersen; P Lo
Journal:  Experientia       Date:  1996-10-31

5.  Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Authors:  R G Allen
Journal:  Age (Omaha)       Date:  1998-04

6.  Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-q11.

Authors:  Y Sanchez; M Lovell; M C Marin; P E Wong; M E Wolf-Ledbetter; T J McDonnell; A M Killary
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

7.  Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.

Authors:  Uddalak Bharadwaj; Christian Marin-Muller; Min Li; Changyi Chen; Qizhi Yao
Journal:  Mol Cancer       Date:  2011-08-31       Impact factor: 27.401

8.  Bi-transgenic mice reveal that K-rasVal12 augments a p53-independent apoptosis when small intestinal villus enterocytes reenter the cell cycle.

Authors:  C M Coopersmith; C Chandrasekaran; M S McNevin; J I Gordon
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

9.  Massive programmed cell death in intestinal epithelial cells induced by three-dimensional growth conditions: suppression by mutant c-H-ras oncogene expression.

Authors:  J Rak; Y Mitsuhashi; V Erdos; S N Huang; J Filmus; R S Kerbel
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

Review 10.  Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases.

Authors:  Ting Liu; Yu Zhou; Kwang Suk Ko; Heping Yang
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.